The European Medicines Agency has updated its guidance documents for companies on the submission of variations to marketing authorizations (MAs) in preparation for 1 January 2025, when the provisions of the amended EU Variations Regulation are due to apply.
Among the areas addressed by the updated guidance are minor Type IA variation procedures, the Article 5 procedure for classifying...